for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Applied DNA Sciences Inc

APDN.OQ

Latest Trade

0.22USD

Change

0.01(+3.77%)

Volume

32,898

Today's Range

0.20

 - 

0.22

52 Week Range

0.17

 - 

1.40

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
0.21
Open
0.22
Volume
32,898
3M AVG Volume
11.36
Today's High
0.22
Today's Low
0.20
52 Week High
1.40
52 Week Low
0.17
Shares Out (MIL)
48.02
Market Cap (MIL)
10.29
Forward P/E
-1.00
Dividend (Yield %)
--

Next Event

Applied DNA Sciences Inc Annual Shareholders Meeting

Latest Developments

More

Applied DNA Sciences Announces Q3 Loss Per Share $0.04

Applied DNA Signs Master Services Agreement With Schreiner Group To Deliver Signature DNA Labels To Protect Pharmaceutical Supply Chains

Applied DNA And Theracann International Sign Term Sheet To Amend Licensing And Cooperation Agreement

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Applied DNA Sciences Inc

Applied DNA Sciences, Inc. is engaged in creating security solutions addressing the challenges of modern commerce. The Company is also engaged in the large-scale production of specific deoxyribonucleic acid (DNA) sequences using the polymerase chain reaction (PCR). Its principal technology platform includes SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon. Its SigNify IF portable DNA reader provides definitive real-time authentication of SigNature DNA in the field-DNA becomes a solution for supply chain integrity. SigNature DNA is the Company's platform ingredient, at the core of all its security solutions. It provides forensic power and protection for a range of applications. SigNature T DNA is a tagging and authentication system specifically designed for textiles and apparel. DNAnet is a DNA marker that can be used to definitively link evidence and offenders to specific crime scenes and help return stolen or lost property to its rightful owner.

Industry

Chemical Manufacturing

Contact Info

50 Health Sciences Dr

+1.631.2408800

http://www.adnas.com/

Executive Leadership

James A. Hayward

Chairman of the Board, President, Chief Executive Officer

Beth M. Jantzen

Chief Financial Officer

Judith Murrah

Chief Information Officer

Ming-Hwa Liang

Secretary, Strategic Technology Development Officer

Robert B. Catell

Director

Key Stats

3.00 mean rating - 1 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.0K

2017

0.0K

2018

0.0K

2019(E)

0.0K
EPS (USD)

2016

-0.510

2017

-0.490

2018

-0.400

2019(E)

-0.190
Price To Earnings (TTM)
--
Price To Sales (TTM)
2.09
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
-483.03
Return on Equity (TTM)
-226.71

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up